2022 - Research.com Best Female Scientist Award
Parkinson's disease, Disease, Internal medicine, Parkinsonism and Degenerative disease are her primary areas of study. The Parkinson's disease study combines topics in areas such as Dopaminergic, Anesthesia, Psychiatry and Risk factor. Her Disease research is multidisciplinary, incorporating perspectives in Epidemiology, Incidence, Molecular genetics and Neurology, Neuroscience.
She usually deals with Incidence and limits it to topics linked to Gerontology and Confidence interval. The various areas that Caroline M. Tanner examines in her Internal medicine study include Physical therapy, Oncology and Cardiology. The study incorporates disciplines such as Lewy body, Senescence, Paraquat and Mitochondrion in addition to Degenerative disease.
Her scientific interests lie mostly in Parkinson's disease, Disease, Internal medicine, Cohort and Physical therapy. Her work carried out in the field of Parkinson's disease brings together such families of science as Biomarker, Psychiatry, Epidemiology and Parkinsonism. Her Disease research integrates issues from Clinical trial, Physical medicine and rehabilitation, Gerontology, Intensive care medicine and Neuroscience.
Her study looks at the relationship between Internal medicine and topics such as Cardiology, which overlap with Heart rate variability. Her Physical therapy study also includes fields such as
Her primary scientific interests are in Parkinson's disease, Disease, Internal medicine, Cohort and Movement disorders. Her study explores the link between Parkinson's disease and topics such as Placebo that cross with problems in Bedtime. Her study in the field of Motor symptoms is also linked to topics like Pandemic.
The concepts of her Internal medicine study are interwoven with issues in Gastroenterology and Oncology. Her Cohort research incorporates themes from Clinical research, Observational study, Clinical trial, Schizophrenia and Biomarker. She has researched Movement disorders in several fields, including Family medicine, Neurology and MEDLINE.
Her main research concerns Parkinson's disease, Disease, Internal medicine, Cohort and Movement disorders. She combines subjects such as Psychiatry, Adverse effect, Epidemiology and Cohort study with her study of Parkinson's disease. Her Disease research focuses on Alzheimer's disease in particular.
Her research integrates issues of Oncology and Rating scale in her study of Internal medicine. Her Cohort research focuses on Prospective cohort study and how it connects with Schizophrenia, Antipsychotic, Schizoaffective disorder and Physical therapy. Her work deals with themes such as Global health, Dopamine transporter, Outpatient clinic and Family medicine, which intersect with Movement disorders.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Levodopa and the progression of Parkinson's disease.
Fahn S;Oakes D;Shoulson I;Kieburtz K.
The New England Journal of Medicine (2004)
Projected number of people with parkinson disease in the most populous nations, 2005 through 2030
E. R. Dorsey;R. Constantinescu;R. Constantinescu;J. P. Thompson;K. M. Biglan.
Incidence of Parkinson’s Disease: Variation by Age, Gender, and Race/Ethnicity
Stephen K. Van Den Eeden;Caroline M. Tanner;Allan L. Bernstein;Robin D. Fross.
American Journal of Epidemiology (2003)
Variable expression of Parkinson's disease A base‐line analysis of the DAT ATOP cohort
Joseph Jankovic;Michael P McDermott;Jonathan T Carter;Susan A Gauthier.
Rotenone, Paraquat, and Parkinson’s Disease
Caroline M Tanner;Freya Kamel;G Webster Ross;Jane A Hoppin.
Environmental Health Perspectives (2011)
Parkinson Disease in Twins: An Etiologic Study
C. M. Tanner;R. Ottman;S. M. Goldman;J. Ellenberg.
The Parkinson Progression Marker Initiative (PPMI)
Kenneth Marek;Danna Jennings;Shirley Lasch;Andrew Siderowf.
Progress in Neurobiology (2011)
Association of Coffee and Caffeine Intake With the Risk of Parkinson Disease
Ross Gw;Abbott Rd;Petrovitch H;Morens Dm.
Frequency of bowel movements and the future risk of Parkinson’s disease
R. D. Abbott;H. Petrovitch;L. R. White;K. H. Masaki.
Association of olfactory dysfunction with risk for future Parkinson's disease.
G. Webster Ross;Helen Petrovitch;Robert D. Abbott;Caroline M. Tanner.
Annals of Neurology (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: